Ro CEO Zach Reitano on Building a New AI Agent for Patient Care

Zach Reitano, co-founder and CEO of Ro, has spent nine years adapting the healthcare company to shifting patient needs, from early direct-to-patient services to GLP-1 treatments. In a recent interview, Reitano shared insights into the development of Ro's new AI agent, designed to enhance patient interactions and streamline care. The AI agent aims to handle routine inquiries, assist with medication management, and provide personalized health recommendations, reflecting Ro's commitment to innovation in telehealth. As healthcare increasingly embraces artificial intelligence, Ro's initiative positions the company at the forefront of tech-driven patient care. Reitano's leadership highlights a broader industry trend toward integrating AI to improve efficiency and patient outcomes. The move signals Ro's ambition to remain competitive in the rapidly evolving digital health landscape.